Dinglin and colleagues also indicated that ectopic RYBP expression impeded cancer cell proliferation and tumour progression via the EGFR‐ERK/AKT signalling pathway, as well as inhibiting lung cancer metastasis by reversing epithelial–mesenchymal transition (EMT) 64. Here, RYBP is linked to lung cancer.